BEAM
Beam Therapeutics Inc.Company with tickers: BEAM
CIK
1745999
CUSIP
07373V105
Shares Outstanding
102,879,214
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $31,738,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $138,953,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $104,524,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-107,215,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-94,318,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.91 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.91 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |